BriaCell Therapeutics Corp. (BCTX) Times Interest Earned (2021 - 2026)

BriaCell Therapeutics has reported Times Interest Earned for 6 years, with the latest figure at -$257.19 in Q2 2026.

• Quarterly Times Interest Earned fell 50.29% year-over-year to -$257.19 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$914.57 (down 189.14% YoY) and the FY2025 annual result came in at -$1.12, up 39.5% from the prior year.
• Times Interest Earned climbed to -$257.19 in Q2 2026 per BCTX's latest filing, from -$15062.5 in the prior quarter.
• Over five years, Times Interest Earned peaked at $224.46 in Q3 2025 and troughed at -$15411.5 in Q3 2023.
• A 5-year average of -$2637.7 and a median of -$193.56 in 2025 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2025: Times Interest Earned slumped 434.64% in 2022, then soared 108.21% in 2025.
• Over 5 years, Times Interest Earned stood at -$51.17 in 2022, then sank by 361.62% to -$236.2 in 2023, then surged by 42.76% to -$135.21 in 2024, then sank by 43.15% to -$193.56 in 2025, then tumbled by 32.88% to -$257.19 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$257.19, -$15062.5, and -$193.56 for Q2 2026, Q1 2026, and Q4 2025 respectively.